Resultados de la búsqueda 11-20 of 12474 for Acute kidney injury

  1. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    REstrictive versus LIberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI). Rochester, Minn. The objective of this ...

  2. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    REstrictive versus LIberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI). Rochester, Minn. The objective of this ...

  3. Nefrología e hipertensión - Ensayos clínicos

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

  4. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ... acute kidney injury provides strong predictive ability for AKI and potential therapeutic targets. Numeración de páginas Estudios clínicos. AnteriorPágina ...

  5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

  6. Nefrología e hipertensión - Ensayos clínicos

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

  7. Nefrología e hipertensión - Ensayos clínicos

    ... acute kidney injury provides strong predictive ability for AKI and potential therapeutic targets. Numeración de páginas Estudios clínicos. AnteriorPágina ...

  8. Nefrología e hipertensión - Ensayos clínicos

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

  9. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    REstrictive versus LIberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI). Rochester, Minn. The objective of this ...

  10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    REstrictive versus LIberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI). Rochester, Minn. The objective of this ...